Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlife

American Journal of Epidemiology

Volumn 177, Issue 8, 2013, Pages 810-817

  Ylitalo, Kelly R ^a   Herman, William H ^a   Harlow, Siobán D ^a  

^a not available   (United States)

Author keywords

peripheral nerve dysfunction; peripheral neuropathy; physical functioning

Indexed keywords

AGE CLASS; COHORT ANALYSIS; DISABILITY; EPIDEMIOLOGY; NEUROLOGY; PERFORMANCE ASSESSMENT; WALKING; WOMENS HEALTH; WORLD HEALTH ORGANIZATION;

ARTICLE; BODY MASS; CLIMBING; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; PERIPHERAL NEUROPATHY; PHYSICAL PERFORMANCE; QUESTIONNAIRE; SITTING; STANDING; WALKING;

MICHIGAN; UNITED STATES;

EID: 84876249754     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws327     Document Type: Article

References (27)

1. US Department of Health and Human Services. Healthy People 2020 Framework. Washington, DC:Department of Health and Human Services; 2010. (http://healthypeople.gov/2020/ Consortium/HP2020Framework.pdf). (Accessed April 28, 2010).
2. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults:National Health Interview Survey, 2009. Vital Health Stat 10. 2010;249:1-207.
3. Centers for Disease Control and Prevention. Prevalence and most common causes of disability among adults-United States, 2005. MMWR Morb Mortal Wkly Rep. 2009; 58(16):421-426.
4. van Schie CH. Neuropathy:mobility and quality of life. Diabetes Metab Res Rev. 2008;24(supp 1):S45-S51.
5. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the U.S. adult population [greater than or equal to] 40 years of age with and without diabetes. Diabetes Care. 2004;27(7):1591-1597.
6. Ylitalo K, Sowers MF, Heeringa S. Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity. Diabetes Care. 2011;34(7):1642-1647.
7. Tesfaye S, Boulton AJ, eds. Diabetic Neuropathy. Oxford, United Kingdom:Oxford University Press; 2009.
8. Dyck PJ, Dyck PJB, Klein CJ, et al. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve. 2007;36(4):536-541.
9. Ziegler D, Rathman W, Dickhaus T, et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy. Diabetes Care. 2008;31(3):464-469.
10. Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci. 2006;242(1-2):9-14.
11. Sowers MF, Crawford S, Sternfeld B, et al. SWAN:a multi-center, multi-ethnic, community-based cohort study of women and the menopause. In:Lobo R, Kelsey J, Marcus R, eds. Menopause:Biology and Pathobiology. San Diego, CA:Academic Press, 2000:175-178.
12. Feldman EL, Stevens MJ. Clinical testing in diabetic peripheralneuropathy. Can JNeurol Sci. 1994;21(4):S3-S7.
13. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications:use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76(1):68-71.
14. Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes:results from the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29(7):937-944.
15. Nang EE, Khoo CM, Tai ES, et al. Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease? The Singapore Prospective Study Program. Am J Epidemiol. 2009;169(12):1454-1462.
16. Dyck PJ, Karnes JL, Daube J, et al. Clinical and neuropathological criteria for the diagnosis and staging ofdiabeticpolyneuropathy. Brain. 1985;108(Pt4):861-880.
17. Resnick HE, Vinik AI, Schwartz AV, et al. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age:the Women's Health and Aging Study. Diabetes Care. 2000;23(11):1642-1647.
18. Strotmeyer ES, de Rekeneire N, Schwartz AV, et al. The relationship between reduced peripheral nerve function and diabetes with physical performance in older white and black adults. Diabetes Care. 2008;31(9):1767-1772.
19. Webber SC, Porter MM, Menec VH. Mobility in older adults:acomprehensive framework. Gerontologist. 2010;50(4):443-450.
20. US Department of Transportation Federal Highway Administration. Manual on Uniform Traffic Control Devices for Streets and Highways. Washington, DC:US Department of Transportation Federal Highway Administration; 2009. (http:// mutcd.fhwa.dot.gov/pdfs/2009/coverintrotoc.pdf). (Accessed August 19, 2011).
21. Sowers M, Jannausch ML, Gross M, et al. Performance-based physical functioning in African-American and Caucasian women at midlife:considering body composition, quadriceps strength, and knee osteoparthritis. Am J Epidemiol. 2006; 163(10):950-958.
22. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl JMed. 1995; 332(9):556-561.
23. Guralnik JM, Ferrucci L, Peiper CF, et al. Lower extremity function and subsequent disability:consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance batter. J Gerontol A Biol Sci Med Sci. 2000;55(4):M221-M231.
24. Courtemanche R, Teasdale N, Boucher P, et al. Gait problems in diabetic neuropathic patients. Arch Phys Med Rehabil. 1996;77(9):849-855.
25. Verbrugge LM, Jette AM. The disablement process. Soc Sci Med. 1994;38(1):1-14.
26. Gallagher EJ, Le Roith D, Karnieli E. The metabolic syndrome- from insulin resistance to obesity and diabetes. Med Clin NAm. 2011;95(5):855-873.
27. Tesfaye S, Selvarajah D. The Eurodiab study:what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009;9(6):432-434.